Logo for MindBio Therapeutics Corp.
MBIO
0.00%

MindBio Therapeutics Corp.

Status
ActiveT2
Issued & Outstanding7,283,063
Reserved for Issuance5,378,855
CurrencyCAD
CSE IndexNo

Quote

Last Price—0.00 (0.00%)
Volume0
Change0.00
Bid Size
0
Bid Price—
Ask Price—
Ask Size
0
Prev Close—
Open—
Day High—
Day Low—
52 Week High
—
52 Week Low
—

MindBio Therapeutics Corp.

Charts by TradingView

Depth Display

Recent Trades

About

MindBio Therapeutics Corp.

Listing Date
May 05, 2023
MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning.  The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations.  The Company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.